Recurrent Oxaliplatin-Induced Immune Hemolytic Anemia by Chemotherapy for Metastatic Colon Cancer: A Case Report

Abstract

<p> <span>We report herein the case of a 55</span><span>-</span><span>year</span><span>-</span><span>old man who presented an acute hemolysis following a 6th cycle of FOLFOX regimen for a metastatic colorectal cancer; this patient had previously received 12 cycles in an adjuvant setting. He had presented attenuated signs during the previous cycle. This corresponded to an oxaliplatin-induced immune hemolytic anemia. This unfrequent side effect of oxaliplatin needs to be known in order to avoid severe complications.</span><span></span> </p> <p> <span></span> </p